The Stanford Headache Program Clinical Trials

A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine (HFEM)

Principal Investigator: Sheena Aurora, MD 

Status: recruitment ended

A Phase II, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Chronic Migraine Prevention

Principal Investigator: Sheena Aurora, MD

Status: recruitment ended

Assessment of LBR-101 in Chronic Migraine

Principal Investigator: Sheena Aurora, MD

Status: recruitment ended

Migraine Prophylaxis with BOTOX in Adults

Principal Investigator: Meredith Barad, MD 

Status: recruitment ended

Migraine Prophylaxis with BOTOX in Children

Principal Investigator: Meredith Barad, MD

Status: recruitment ended

Non-Invasive Neurostimulation of the Vagus Nerve with the Gammacore Device for the Treatment of Cluster Headache

Principal Investigator: Sheena Aurora, MD

Status: recruitment ended

Screening Tool Validation for Chronic Migraine

Principal Investigator: Nada Hindiyeh, MD 

Status: Currently recruiting via CHOIR

For more information on our clinical trials

Maria Coburn
Clinical Research Manager
mcoburn@stanford.edu

(650) 736-9551